Circular RNA circPDE4D Protects against Osteoarthritis by Binding to miR-103a-3p and Regulating FGF18
Yizheng Wu,Zhenghua Hong,Wenbin Xu,Junxin Chen,Qingxin Wang,Jiaxin Chen,Weiyu Ni,Zixuan Mei,Ziang Xie,Yan Ma,Jiying Wang,Jianhong Lu,Chao Chen,Shunwu Fan,Shuying Shen
DOI: https://doi.org/10.1016/j.ymthe.2020.09.002
IF: 12.91
2021-01-01
Molecular Therapy
Abstract:<h2 class="section-title u-h3 u-margin-l-top u-margin-xs-bottom">Abstruct</h2><p>Osteoarthritis (OA) is a common, age-related and painful disease characterized by cartilage destruction, osteophyte formation and synovial hyperplasia. This study revealed that circPDE4D, a circular RNA derived from human linear PDE4D, plays a critical role in maintaining the extracellular cellular matrix (ECM) during OA progression. CircPDE4D was significantly downregulated in OA cartilage tissues and during stimulation with inflammatory cytokines. The knockdown of circPDE4D predominantly contributed to Aggrecan loss and the upregulation of matrix catabolic enzymes, including MMP3, MMP13, ADAMTS4 and ADAMTS5, but not proliferation or apoptosis. In a murine model of destabilization of the medial meniscus (DMM), the intraarticular injection of circPDE4D alleviated DMM-induced cartilage impairments. Mechanistically, we found that circPDE4D exerted its effect by acting as a sponge for miR-103a-3p and thereby regulated FGF18 expression, which is a direct target of miR-103a-3p. In conclusion, our findings highlight a novel protective role of circPDE4D in OA pathogenesis and indicate that the targeting of the circPDE4D-miR-103a-3p-FGF18 axis might provide a potential and promising approach for OA therapy.</p>
genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology